1. Management of Type 2 Diabetes Mellitus and Cardiovascular Risk

   • Hannele Yki-Järvinen

   Leading Article 17 September 2012 Pages: 975 - 983

   

2. Drug Treatment of Tropical Parasitic Infections

   • Iain Stephenso
   • Martin Wiselka

   Leading Article 17 September 2012 Pages: 985 - 995

   

3. Effects of β-Blockers on Neurohormonal Activation in Patients with Congestive Heart Failure

   • David Baran
   • Evelyn M. Horn
   • Stuart D. Katz

   Review Article 17 September 2012 Pages: 997 - 1016

   

4. Antidiabetic Drugs Present and Future

   • Ian W. Campbell

   Review Article 17 September 2012 Pages: 1017 - 1028

   

5. Anticonvulsants for Neuropathic Pain Syndromes

   • Ivo W. Tremont-Lukats
   • Carla Megeff
   • Misha-Miroslav Backonja

   Review Article 17 September 2012 Pages: 1029 - 1052

   

6. The Treatment of Respiratory Pseudomonas Infection in Cystic Fibrosis

   • Dev Banerjee
   • David Stableforth

   Disease Management 17 September 2012 Pages: 1053 - 1064

   

7. Ropivacaine

   • Karen J. McClellan
   • Diana Faulds

   Adis Drug Evaluation 17 September 2012 Pages: 1065 - 1093

   

8. Galantamine

   • Lesley J. Scott
   • Karen L. Goa

   Adis Drug Evaluation 17 September 2012 Pages: 1095 - 1122

   

9. Lercanidipine

   • Karen J. McClellan
   • Blair Jarvis

   Adis Drug Evaluation 17 September 2012 Pages: 1123 - 1140

   

10. Budesonide Inhalation Suspension

    • Karen M. Hvizdos
    • Blair Jarvis

    Adis Drug Evaluation 17 September 2012 Pages: 1141 - 1178

    

11. Cerivastatin

    • Greg L. Plosker
    • Christopher J. Dunn
    • David P. Figgitt

    Adis Drug Evaluation 17 September 2012 Pages: 1179 - 1206

    

12. Inhaled Salmeterol/Fluticasone Propionate Combination

    • Anthony Markham
    • Blair Jarvis

    Adis Drug Evaluation 17 September 2012 Pages: 1207 - 1233